Ticker Launch

SPAC · Merger completed

LifeSci Acquisition II Corp.

Business combination with Science 37, Inc.

LifeSci Acquisition II Corp. is a blank-check company (SPAC) that raised $75M in its initial public offering on Nov 23, 2020, listing on Nasdaq Capital Market. It completed its business combination with Science 37, Inc. on Oct 6, 2021; the combined company is Science 37 Holdings, Inc. (SNCE). LifeSci Holdings led the IPO, with Chardan. Loeb & Loeb advised the SPAC and Ellenoff Grossman & Schole advised the underwriters on the IPO.

Science 37, Inc. is an early developer of decentralized clinical trials. Its operating system for clinical research enables workflow orchestration, evidence generation and data harmonization, supported by telemedicine investigators, mobile nurses, remote coordinators, patient communities and connected devices.

Status
Merger completed
IPO date
Nov 23, 2020
IPO size
$75M
IPO exchange
Nasdaq Capital Market
Target
Science 37, Inc. (Legacy)
Announced
May 7, 2021
Closed
Oct 6, 2021
Combined company
Science 37 Holdings, Inc. (SNCE)
IPO underwriters
LifeSci Holdings and Chardan
SPAC counsel (IPO)
Loeb & Loeb
Underwriters' counsel (IPO)
Ellenoff Grossman & Schole

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2021